

浏览全部资源
扫码关注微信
1.重庆市中药研究院 重庆市药物安全评价中心,重庆 400065;
2.浙江中医药大学 药学院,杭州 310053
Received:24 March 2019,
Published Online:19 June 2019,
Published:05 October 2019
移动端阅览
Xue YANG, Fei ZHOU, Yang YANG, et al. Effect of Puerarin Combined with Tanshinone ⅡA on t-PA, PAI-1 and Oxidative Stress in DM Rats with Vascular Lesions[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(19): 46-54.
Xue YANG, Fei ZHOU, Yang YANG, et al. Effect of Puerarin Combined with Tanshinone ⅡA on t-PA, PAI-1 and Oxidative Stress in DM Rats with Vascular Lesions[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(19): 46-54. DOI: 10.13422/j.cnki.syfjx.20191905.
目的:
2
观察葛根素联合丹参酮Ⅱ
A
对糖尿病血管病变大鼠的保护作用及其相关机制。
方法:
2
高脂饲料喂养SD大鼠给予尾静脉注射链脲佐菌素(STZ)制作糖尿病血管病变模型,将造模成功大鼠随机分为模型组,葛根素联合丹参酮Ⅱ
A
高(0.5 g·kg
-1
+1.0 g·kg
-1
),中(0.25 g·kg
-1
+0.5 g·kg
-1
),低剂量组(0.05 g·kg
-1
+0.1 g·kg
-1
),丹参酮Ⅱ
A
(0.5 g·kg
-1
)组,葛根素(0.25 g·kg
-1
)组,二甲双胍药(二甲双胍,0.09 g·kg
-1
)组,每组10只,连续灌胃给药70 d。观察实验各组药物干预后大鼠体质量及一般情况;采用全自动生化分析仪检测大鼠血糖、血脂含量;采用酶联免疫吸附测定(ELISA)检测大鼠血清胰岛素(INS),晚期糖基化终末产物(AGEs),超氧化物歧化酶(SOD),谷胱甘肽过氧化物酶(GSH-Px)含量,血浆组织纤溶酶原激活物(t-PA),纤溶酶原激活物抑制物-1(PAI-1),血栓素B
2
(TXB
2
)含量,主动脉匀浆AGEs,氧化型低密度脂蛋白(ox-LDL)含量;采用化学比色法检测大鼠血清丙二醛(MDA)含量;苏木素-伊红(HE)染色观察冠状动脉组织病理学改变;免疫组化观察主动脉PAI-1蛋白表达。
结果:
2
与正常组比较,模型组血糖及血脂明显升高(
P
<
0.05,
P
<
0.01),血清INS,AGEs,MDA含量明显增加(
P
<
0.05,
P
<
0.01),血浆PAI-1,TXB
2
含量显著增加(
P
<
0.01),主动脉匀浆AGEs,ox-LDL含量显著增加(
P
<
0.01),血清SOD,GSH-Px水平显著降低(
P
<
0.01),血浆t-PA含量明显降低(
P
<
0.05),主动脉组织PAI-1蛋白表达明显增加(
P
<
0.05);与模型组比较,葛根素联合丹参酮 Ⅱ
A
可降低血糖及血脂水平(
P
<
0.05,
P
<
0.01),降低血清INS,AGEs,MDA含量(
P
<
0.05,
P
<
0.01),降低血浆PAI-1,TXB
2
含量(
P
<
0.05,
P
<
0.01),降低主动脉匀浆AGEs,ox-LDL含量(
P
<
0.05,
P
<
0.01),升高血清SOD,GSH-Px含量(
P
<
0.05,
P
<
0.01),升高血浆t-PA含量(
P
<
0.05,
P
<
0.01),减轻冠状动脉组织病变,降低主动脉组织PAI-1蛋白表达(
P
<
0.05),其效果好于单药。
结论:
2
葛根素联合丹参酮Ⅱ
A
能减轻糖尿病大鼠血管病变,其机制可能与减轻氧化应激,调节凝血-纤溶系统有关。
Objective:
2
To observe the protective effect and mechanism of combination of puerarin combined with tanshinone Ⅱ
A
on diabetes mellitus (DM) rats with vascular lesions.
Method:
2
The SD rats (fed with high-fat diet) were administrated with streptozotocin(STZ) through intravenous injection to make the model of diabetic vascular lesions. The successfully modeled rats were randomly divided into the model control group
the high-dose group (0.5 g·kg
-1
+ 1.0 g·kg
-1
)
the middle-dose group (0.25 g·kg
-1
+ 0.5 g·kg
-1
)
the low-dose group (0.05 g·kg
-1
+ 0.1 g·kg
-1
)
the puerarin group (0.25 g·kg
-1
)
the tanshinone Ⅱ
A
group (0.5 g·kg
-1
) and the positive control group (Metformin
0.09 g·kg
-1
). Each group was administrated with drugs respectively by gavage for 70 days. After intervention in each group
the general conditions and body weight of the rats were observed. The contents of blood grucose and blood lipids were determined by automatic biochemical analyzer. The contents of insulin
advanced glycation end products (AGEs)
superoxide dismutase(SOD)
glutathione peroxidase (GSH-Px) in serum
the contents of tissue plasminogen activator (t-PA)
plasminogen activator inhibitor-1 (PAI-1) and thromboxane B
2
(TXB
2
) in plasma
as well as the contents of AGEs and oxidized low-density lipoprotein(ox-LDL) in aorta homogenate were detected by enzyme-linked immunosorbent assay(ELISA). The content of malondialdehyde(MDA) in serum was determined by chemical colorimetry. Pathological changes of coronary tissue were observed by htoxylin eosin(HE) staining. The expression of PAI-1 protein of aorta was observed by immunohistochemistry.
Result:
2
Compared with the normal control group
in the model group
the levels of blood grucose and blood lipids (
P
<
0.05
P
<
0.01)
the contents of insulin
AGEs and MDA in serum (
P
<
0.05
P
<
0.01)
the contents of PAI-1 and TXB
2
in plasma (
P
<
0.01)
and the contents of AGEs and ox-LDL in aorta homogenate were increased(
P
<
0.01). The contents of SOD and GSH-Px in serum (
P
<
0.01)
the contents of t-PA in plasma were decreased(
P
<
0.05)
whereas the expression of PAI-1 protein of aorta was increased (
P
<
0.05). Compared with the model group
in the drug intervention group
the levels of blood grucose and blood lipids (
P
<
0.05
P
<
0.01)
the contents of insulin
AGEs and MDA in serum (
P
<
0.05
P
<
0.01)
the contents of PAI-1 and TXB
2
in plasma (
P
<
0.05
P
<
0.01)
and the contents of AGEs and ox-LDL in aorta homogenate were decreased(
P
<
0.05
P
<
0.01)
whereas the contents of SOD and GSH-Px in serum and the contents of t-PA in plasma were increased(
P
<
0.05
P
<
0.01). The coronary lesions were relieved
and the expression of PAI-1 protein of aorta was reduced (
P
<
0.05). The efficacy of combined medication was better than single drug administration.
Conclusion:
2
Puerarin combined with Tanshinone Ⅱ
A
could relieve vascular lesions of DM rats. The mechanisms may be related to the reduction of oxidative stress and the regulation of coagulation-fibrinolysis system.
刘倩 , 范颖 , 李新 , 等 . 黄芪葛根配伍调节糖尿病大鼠血糖血脂炎症的作用与机制 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 11 ): 81 - 86 .
牟健 , 陈艳 . 姜黄素对大鼠糖尿病血管并发症的保护作用 [J]. 解放军药学学报 , 2017 , 33 ( 5 ): 418 - 421 .
刘威 . 抗氧化应激药物防治糖尿病血管并发症的研究进展 [J]. 中山大学研究生学刊:自然科学、医学版 , 2007 , 28 ( 4 ): 17 - 23 .
盛宏光 , 邱凌 , 黄薇 , 等 . 葛根素对2型糖尿病vWF、t-PA及PAI-1含量的影响 [J]. 浙江中西医结合杂志 , 2009 , 19 ( 9 ): 559 - 561 .
CHEN G , ZHANG X , LI C , et al . Role of the TGFβ/p65 pathway in tanshinone ⅡA-treated HBZY 1 cells [J]. Mol Med Rep , 2014 , 10 ( 5 ): 2471 - 2476 .
LIU Y , WANG L , LI X , et al . Tanshinone ⅡA improves impaired nerve functions in experimental diabetic rats [J]. Biochem Biophys Res Commun , 2010 , 399 ( 1 ): 49 - 54 .
曹慧敏 , 吴瑾 , 贾连群 , 等 . 丹参酮ⅡA对心血管系统药理作用的研究进展 [J]. 世界中医药 , 2017 , 12 ( 7 ): 1718 - 1722 .
李玉萍 , 顾兵 , 刘建涛 , 等 . 丹参酮ⅡA的研究进展 [J]. 时珍国医国药 , 2010 , 21 ( 7 ): 1770 - 1772 .
郝颖 , 柴瑞华 , 于世家 . 改良链脲佐菌素(STZ)诱导大鼠糖尿病模型及其饲养方法 [J]. 中华中医药学刊 , 2008 , 26 ( 4 ): 784 - 785 .
席秋江 , 韩莉 , 楼小亮 . 糖尿病大鼠模型的实验室研究 [J]. 江西医药 , 2017 , 52 ( 12 ): 1295 - 1296 .
魏占英 , 沈丽 , 冯晓慧 , 等 . 高脂饲料喂养时间和STZ剂量对建立2型糖尿病大鼠模型的影响 [J]. 医学研究杂志 , 2014 , 43 ( 2 ): 42 - 46 .
Rask-Madsen C , King G . Vascular complications of diabetes: mechanisms of injury and protective factors [J]. Cell Metabolism , 2013 , 17 ( 1 ): 20 - 33 .
Lobato N S , Filgueira F P , Hagihara G N , et al . Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats [J]. Life Sci , 2012 , 90 ( 5/6 ): 228 - 235 .
舒畅 , 范强 , 杨丽霞 , 等 . 昆仑雪菊提取物对糖尿病大鼠胰岛素抵抗IRS-1/PI3K/GLUT4信号通路的影响 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 11 ): 122 - 127 .
王桂红 , 朱(王献) , 吴勇 , 等 . 消渴胶囊对2型糖尿病模型大鼠血糖和血脂的作用 [J]. 中国实验方剂学杂志 , 2014 , 20 ( 17 ): 171 - 174 .
黄链莎 , 刘铜华 , 孙文 , 等 . 桑叶黄酮对糖尿病大鼠血糖水平的影响及机制探讨 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 16 ): 152 - 156 .
侯志涛 , 韩玉生 , 刘翼天 , 等 . 孔圣枕中丹对2型糖尿病大鼠认知功能的影响 [J]. 中国中药杂志 , 2018 , 43 ( 22 ): 4506 - 4512 .
刘博 , 于春江 , 孟祥宝 , 等 . 芪蛭降糖胶囊对2型糖尿病大鼠肝组织中InsR,PI3K,GLUT2,p-JNK蛋白表达的影响 [J]. 中国中药杂志 , 2016 , 41 ( 11 ): 1978 - 1982 .
高家荣 , 庄星星 , 魏良兵 , 等 . 丹蛭降糖胶囊治疗2型糖尿病血管病变的作用机制研究 [J]. 中药药理与临床 , 2014 , 30 ( 6 ): 143 - 145 .
0
Views
12
下载量
5
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621